IL‐2 is a growth factor and important cytokine for the survival and proliferation of Tregs and T effector cells,106, 107 and therefore administrating low doses of recombinant IL‐2 in COVID‐19 patients should resolve lymphopenia and restore normal T‐cell counts. The gene discussed is IL2; the disease is lymphopenia.